Skip to content

Menu
  • USC Stem Cell
  • About
    • Stem Cell FAQs
    • Mission and History
    • California’s Leadership in Stem Cell Research
    • Founding Supporters and Ambassadors
    • Well-being
    • Jobs
  • News & Events
    • News
    • Events
    • Videos
    • Impact Reports and Newsletters
  • Research
    • Department Faculty
    • Eli and Edythe Broad Center Faculty
    • Research Facilities
    • USC+CHLA Alpha Clinic
    • Translational Research Committee
    • USC Stem Cell Research Oversight Committee (SCRO)
    • Apply to Become Center Faculty
  • Education & Training
    • Undergraduate
    • Master’s Program
    • PhD Program
    • Medical Education
    • Postdoctoral Opportunities
    • Our Trainees
  • Funding
  • Inclusive Excellence
  • Support Us
  • Contact
    • Directory
    • Subscribe
  • Search

USC Stem Cell scientists use “mini-lungs” and lung models to understand COVID-19

By  Cristy Lytal

Posted June 27, 2020
Reading Time 3 minutes

in this section

  • News
  • Events
  • Videos
  • Impact Reports and Newsletters

read this next

Ya-Wen Chen

USC Stem Cell scientist Ya-Wen Chen grows miniature lungs with maximum potential

  • Follow us on
  • Like us on
  • Follow us on
  • Follow us on
SARS-CoV-2
This scanning electron microscope image shows SARS-CoV-2 (yellow), the virus that causes COVID-19. (Image courtesy of the National Institute of Allergy and Infectious Diseases)

USC scientists are testing out experimental COVID-19 treatments on human “mini-lungs” and lung models, grown in the laboratory using stem cells. With names such as organoids and lung-chips, these simplified, lung-like structures are critically useful for studying infection and for screening large numbers of drug-like molecules to identify promising leads.

Ya-Wen Chen—a new assistant professor of medicine, and stem cell biology and regenerative medicine, and a member of the USC Hastings Center for Pulmonary Research—is using lung organoids to test a potential antiviral treatment to protect against the SARS-CoV-2 coronavirus that causes COVID-19. The antiviral consists of antibodies that block an enzyme called TMPRSS2, which the coronavirus uses to enter the cells lining the lungs via a receptor called ACE2.

To use lung organoids to test another potential antiviral treatment, Chen is collaborating with Justin Ichida, who is the John Douglas French Alzheimer’s Foundation Associate Professor of Stem Cell Biology and Regenerative Medicine at USC and a New York Stem Cell Foundation–Robertson Investigator. Ichida’s team originally identified the potential antiviral, called a kinase, as a drug target for ALS. Blocking the activity of the same kinase also shows promise for protecting lung cells from infection. To support this research, the California Institute for Regenerative Medicine, CIRM, has awarded the team $150,000.

Amy Ryan—an assistant professor of medicine, and stem cell biology and regenerative medicine, and a member of the USC Hastings Center—is studying COVID-19 by using lab-grown lung models, including human Airway Lung-Chips. These structures recapitulate several key characteristics of lung tissue, including airways, blood vessels and blood flow. Ryan’s team is using the Airway Lung-Chip to understand how to modulate the overzealous immune response known as the “cytokine storm” that inflicts severe and even deadly lung damage in certain patients with COVID-19.

To understand another cause of lung damage in COVID-19 patients, Ryan is collaborating with USC scientists Zea Borok, Beiyun Zhou, and Hyungjin Eoh to look at coronavirus infection in the cells of the airway, as well as the cells involved in gas exchange. All of these cells contain networks of membranes, called the endoplasmic reticulum, or ER, which viruses hijack in order to replicate themselves. This hijacking not only allows the virus to multiply, but also stresses out and often kills the lung cells. By studying this stress response, the scientists aim to inform the development of drugs and therapies to inhibit viral replication and lung damage.

Ryan is also leading a multi-disciplinary collaboration to identify genetic risk factors and other biomarkers to predict severe COVID-19 infection, and is providing stem cell-based lung models and pulmonary expertise to several other projects at USC and beyond.

One such project involves Denis Evseenko, an associate professor of orthopaedic surgery, and stem cell biology and regenerative medicine at USC. The Evseenko Lab is studying whether a potential arthritis treatment could also serve as an anti-inflammatory for patients with self-destructive immune reactions to the novel coronavirus.

“When seeking new treatments for a human disease, we need to test these treatments on human cells,” said Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC. “Stem cells offer one of the very best ways to generate and build relevant models of intricate and vital organs such as the human lung in the laboratory. These models enable us to screen large catalogues of molecules to find promising drug candidates, and to perform detailed studies on actual human cells, as we do our utmost to safely and swiftly end the COVID-19 pandemic.”

Read more about: Heart Lung and Blood, Inclusive Excellence
Mentioned in this article: Justin Ichida, PhD, Denis Evseenko, MD, PhD, Andrew P. McMahon, PhD, FRS

Post navigation

← A tribute to patient advocate Nanci Ryder
USC Stem Cell scientists find a simpler way to make sensory hearing cells →
Keck School of Medicine of USC
1975 Zonal Ave.
Los Angeles, CA 90033
Google Map
Phone: (323) 442-1900
Hours:
Monday–Friday
7:30am–5:00pm PST
Resources For
  • Current Students
  • Faculty & Staff
  • Patients
  • Community
  • Press
  • Visitors
Areas of Focus
  • Education & Training
  • Research
  • Patient Care
  • Community
Departments and Offices
  • Departments
  • Institutes and Centers
  • Research Programs
  • Administrative Offices
About Keck
  • History
  • Leadership
  • Annual Report
  • Digital Accessibility
Intranet
  • Privacy Notice
  • Notice of Non-Discrimination
  • Smoke-Free Policy

Copyright © 2025 University of Southern California

  • Research
    • Research HomeCutting-edge research drives innovation in healthcare at the Keck School of Medicine
    • Where Research Happens
    • Research Funding
    • Training and Education
    • Researcher Resources
    • Collaborate and Partner
  • Education
    • Education HomeNurturing future healthcare leaders through excellence in education
    • MD Program
    • Residencies and Clinical Fellowships
    • PhD Programs
    • Master’s Programs
    • Professional Programs
    • Post-Doctoral Researchers
    • CME, Certificate & Undergraduate Programs
  • Departments, Institutes & Centers
    • Basic Science and Clinical DepartmentsExploring foundational science and specialized clinical fields
    • Institutes and Centers
    • Research Programs
  • About
    • About the Keck SchoolDiscover the mission, history, and vision of the Keck School of Medicine
    • History
    • Leadership
    • Dean’s Corner
    • Life in Southern California
    • Visit
  • Our Faculty
  • Current Students
  • Newsroom
  • Events Calendar
  • Support the Keck School
  • USC.edu
  • Are you a Patient?